Descriptor English: | Halothane | ||||
Descriptor Spanish: |
Halotano
| ||||
Descriptor Portuguese: | Halotano | ||||
Descriptor French: | Halothane | ||||
Entry term(s): |
1,1,1-Trifluoro-2-Chloro-2-Bromoethane Fluothane Ftorotan Narcotan |
||||
Tree number(s): |
D02.455.526.340 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D006221 | ||||
Scope note: | A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. NITROUS OXIDE is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178) |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Pharm Action: |
Anesthetics, Inhalation |
||||
Registry Number: | UQT9G45D1P | ||||
CAS Type 1 Name: | Ethane, 2-bromo-2-chloro-1,1,1-trifluoro- | ||||
Public MeSH Note: | BROMCHLORTRIFLUORETHANE was see HALOTHANE 1978-94 |
||||
Online Note: | use HALOTHANE to search BROMCHLORTRIFLUORETHANE 1978-94 |
||||
History Note: | BROMCHLORTRIFLUORETHANE was see HALOTHANE 1978-94 |
||||
DeCS ID: | 6375 | ||||
Unique ID: | D006221 | ||||
NLM Classification: | QV 81 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1963/01/01 | ||||
Date of Entry: | 1999/01/01 | ||||
Revision Date: | 2013/07/08 |
Halothane
- Preferred
Ftorotan
- Narrower
Narcotan
- Narrower
Fluothane
- Narrower
Concept UI |
M0009773 |
Scope note | A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. NITROUS OXIDE is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178) |
Preferred term | Halothane |
Entry term(s) |
1,1,1-Trifluoro-2-Chloro-2-Bromoethane |
Concept UI |
M0351862 |
Preferred term | Ftorotan |
Concept UI |
M0351861 |
Preferred term | Narcotan |
Concept UI |
M0351863 |
Preferred term | Fluothane |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey